IRIS
TORINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.384
EU - Europa 1.650
AS - Asia 508
OC - Oceania 16
SA - Sud America 15
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 22.594
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.343
IT - Italia 515
UA - Ucraina 302
CN - Cina 224
DE - Germania 224
IE - Irlanda 219
GB - Regno Unito 91
FR - Francia 74
KR - Corea 73
FI - Finlandia 65
VN - Vietnam 60
SE - Svezia 43
CA - Canada 37
JP - Giappone 34
TR - Turchia 28
BE - Belgio 24
RU - Federazione Russa 24
IN - India 20
IR - Iran 15
AU - Australia 13
NL - Olanda 13
TW - Taiwan 13
HK - Hong Kong 11
AL - Albania 9
ID - Indonesia 8
CH - Svizzera 7
RO - Romania 7
BR - Brasile 6
EU - Europa 6
GR - Grecia 6
PL - Polonia 6
CL - Cile 5
EG - Egitto 5
NO - Norvegia 5
DK - Danimarca 4
SG - Singapore 4
TH - Thailandia 4
MX - Messico 3
MY - Malesia 3
PT - Portogallo 3
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
KG - Kirghizistan 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
TN - Tunisia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BW - Botswana 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
ET - Etiopia 1
GT - Guatemala 1
IQ - Iraq 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
PG - Papua Nuova Guinea 1
Totale 22.594
Salva come PNG Salva come JPEG
Città #
Woodbridge 6.053
Houston 5.159
Wilmington 5.085
Fairfield 633
Chandler 604
Ann Arbor 454
Ashburn 303
Seattle 266
Jacksonville 250
Rome 209
Cambridge 208
Dublin 208
Medford 155
Beijing 120
Dearborn 102
New York 99
Lawrence 75
Redwood City 57
San Diego 40
Dong Ket 39
Milan 31
Menlo Park 30
Mülheim 27
London 26
Phoenix 25
Nanjing 22
Brussels 20
Sanayi 18
Escondido 16
Lachine 16
New Kensington 16
Norwalk 16
University Park 16
Toronto 13
Falls Church 12
Mountain View 12
Guangzhou 11
Naples 11
Zhengzhou 11
Boardman 10
Florence 9
Hefei 9
Kunming 8
Shanghai 8
Taipei 8
Annapolis 7
Nanchang 7
Engelhard 6
Nürnberg 6
San Jose 6
Seoul 6
Tokyo 6
Baltimore 5
Creede 5
Moniga del Garda 5
Pune 5
Redmond 5
San Giuliano Milanese 5
São Paulo 5
Verona 5
Hanoi 4
Helsinki 4
Istanbul 4
Jinan 4
Kraków 4
Lappeenranta 4
Melbourne 4
Palermo 4
Palo Alto 4
Rho 4
Shenyang 4
Torino 4
Bellinzona 3
Bologna 3
Cedarhurst 3
Champaign 3
Chengdu 3
Chicago 3
Dresden 3
Gorizia 3
Groningen 3
Heidelberg 3
Lancaster 3
Liverpool 3
Los Angeles 3
Lucca 3
Marigliano 3
Montreal 3
North Hollywood 3
Padova 3
Saint Petersburg 3
Surabaya 3
Trani 3
Washington 3
Alimena 2
Amsterdam 2
Ankara 2
Athens 2
Atri 2
Auburn Hills 2
Totale 20.730
Salva come PNG Salva come JPEG
Nome #
Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. 511
La mutualità nel caregiving: una revisione della letteratura 485
Prometheus: A Project for the Dissemination of Knowledge within the Oncology Network of Piedmont and Aosta Valley. 479
A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report 449
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES) 447
Focus on Fotemustine 436
Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells 435
Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. 415
Circulating tumor cells in colorectal cancer patients 411
Prognostic and Predictive Significance of Surrogate Biomarkers of Angiogenesis. 408
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not). 402
Thyroid dysfunction as an unintended side effect of anticancer drugs. 402
A rare case of juvenile hypertension: Coexistence of type 2 multiple endocrine neoplasia -related bilateral pheochromocytoma and reninoma in a young patient with ACE gene polymorphism 402
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 401
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 401
Medullary thyroid cancer: a promising model for targeted therapy. 399
Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives. 397
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors 396
Endocrinological side-effects of immune checkpoint inhibitors 395
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer. 394
Endocrine side effects induced by immune checkpoint inhibitors. 385
Mouse models of medullary thyroid cancer and developing new targeted therapies 385
Thyroid Function Abnormalities in Patients Receiving Anticancer Agents. 384
Targeted therapy of breast cancer. 383
The contribution of targeted therapy to the neoadjuvant chemoradiation of rectal cancer. 378
Endocrine side effects induced by immune checkpoint inhibitors. 378
Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature. 374
Is hypothyroidism a clinically relevant toxicity of tyrosine kinase inhibitors? 371
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. 371
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model 371
Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy 370
Skin acrometastases in squamous cell carcinoma of the tongue. 370
"Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging. 370
Therapeutic agents that inhibit angiogenesis. 370
Genetic and molecular pathophysiology of medullary thyroid cancer. 362
Therapy of breast cancer with molecular targeting agents. 359
Predicting ovarian activity in women affected by early breast cancer: Ameta-analysis-based nomogram 356
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 353
AMBRA1 and SQSTM1 expression pattern in prostate cancer 345
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer. 344
Tailored therapy of colorectal cancer: results, challenges and future directions. 343
Clinical utility of lanreotide autogel® in gastroenteropancreatic neuroendocrine tumors 340
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES). 339
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer. 337
Is tailored therapy feasible in oncology? 334
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 333
Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer. 329
Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all? 323
Combination of antiangiogenic therapy with other anticancer treatment. 322
Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. 320
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease. 318
Failure of a cetuximab/bevacizumab schedule in a patient with metastatic desmoplastic small round-cell tumour refractory to chemotherapy. 317
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer 314
Barriers in the management of cancerrelated pain and strategies to overcome them: findings of a qualitative research involving physicians and nurses in Italy 307
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain? 297
Unusual sites of metastatic malignancy: case 1. Cardiac metastasis in hepatocellular carcinoma. 287
Molecular targeted therapy of medullary thyroid carcinoma 286
Gut microbiota and cancer: From pathogenesis to therapy 164
Lactobacillus rhamnosus GG: An overview to explore the rationale of its use in cancer 159
Role of Mitotane in Adrenocortical Carcinoma - Review and State of the art 136
Drug-induced neoantigen: a new horizon in cancer immunotherapy? 112
Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment Nomograms 97
Development and content validity of the self-care of oral anticancer agents index 78
Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment? 65
Describing self-care behaviours in cancer patients taking oral anticancer agents 59
Urine LOX-1 and volatilome as promising tools towards the early detection of renal cancer 53
Cancer management during COVID-19 pandemic: is immune checkpoint inhibitors-based immunotherapy harmful or beneficial? 52
Indirect basal metabolism estimation in tailoring recombinant human TSH administration in patients affected by differentiated thyroid cancer: A hypothesis-generating study 49
A systematic review of self-care behaviours among patients with cancer who take oral anticancer agents 44
Self-care behaviors in patients with cancer treated with oral anticancer agents: a systematic review 43
Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review 41
Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review 38
La Terza Missione dell'Università: formazione e salute 34
Apoptosis as a Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer 34
A scoping review on the "burned out" or "burnt out" testicular cancer: When a rare phenomenon deserves more attention 28
Metabolic reprogramming of castration-resistant prostate cancer cells as a response to chemotherapy 26
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 26
Self-care behaviours in older adults treated with oral anticancer agents: A qualitative descriptive study 23
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 21
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 20
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 19
Development and Content Validity of the Self-Care of Oral Anticancer Agents Index (SCOAAI) 18
Caregivers’ contribution to self-care for patients treated with oral anticancer agents: A qualitative descriptive study 13
Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition 12
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer 11
Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature 11
Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task 7
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series 7
Unemployment Status Subsequent to Cancer Diagnosis and Therapies: A Systematic Review and Meta-Analysis 7
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives 7
Totale 22.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.342
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.353 0 0 0 0 0 0 0 0 0 0 719 634
2019/20205.891 472 481 411 544 574 647 493 492 490 480 422 385
2020/20213.600 376 435 344 455 344 406 428 321 81 165 148 97
2021/2022939 47 76 41 50 36 72 47 44 53 110 69 294
2022/20231.461 143 156 131 163 107 271 83 94 117 24 126 46
2023/2024455 86 34 32 27 48 108 37 32 22 17 12 0
Totale 22.804